Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SAVA are you kidding me? When do we get news, any guesses?
So When do we expect to see this data released?
Chamath Palihapitiya syas shorts squeezes are a push back against shorts hedgies. Is AVXL next?
SQUEEZE or NEWS COMING? Chamath Palihapitiya says this is a push back against short hedgies.
A short squeeze could have this over $12
Certainly can be part of a short squeeze never seen before.
Billion dollar market cap coming imo. Mark this post as they say.
No Investor would sell on this news
Rett alone is a billion dollar market
Imo. Robinhooders will find NWBO since data lock on phase 3 will be released soon in brain cancer and they are finding AVXL for Alzheimers, Parkinson and Rett.
First article was for her clients, now that the masses are following her she needs to speak more cautiously so no idiot tries to sue her. Smart.
Xena, when do you think we see full details on PD results ?
BE will have Conference call Nov. 18th after the market closes to update entry into commercial hydrogen market and hydrogen powered fuel cells. Dial in number listed on web page.
On Nov. 18th, BE will provide an update on commercial hydrogen and its hydrogen powered fuel cells on a Investot/analyst conference call
Fyi, BE on Nov 18th is holding a CC to update entry into Commercial hydrogen market and its hydrogen powered fuel cells. See PR for call in number.
APVO 3 day move could be NWBO
FDA wont dismiss good data for these patients.
Will there be a stock halt, then a release of news?
Any improvement in survival time is worth multi billions in a worldwide market that is desperate for the FDA to approve ! Physicians and patients will demand it even under the governments administrations approval for compassionate use. This could easily spread to other tumor demands. Buying.
Any Improvement in PDD symptoms, imo should take this to high teens. This oral drug, non IV, has a multi billion worldwide demand awaiting its safe CNS treatments. Even Rett is a billion + market.
BIIB up $100, where can AVXL go?
The enclosed is what the SEC "strongly recommends" in reporting TLD:
Increase visibility. If the data is positive, it can be beneficial to conduct an investor call to discuss the data and answer main questions from analysts and investors. Including a KOL on the call is highly recommended to provide insight into clinical implications of the data, its significance to the current treatment paradigm, clinical demand in the market niche, and to attract more analysts and investors to the call by adding scientific credibility to the discussion.
Consider reporting at conferences. Timing of data readout can be relatively predictable and one can plan to report the full set of data at a medical or scientific conference. One caveat: Keep in mind abstract submission deadlines as well as the conference embargo policy.
Publish peer-reviewed data. Publication in peer-reviewed scientific journals is currently the primary method for sharing clinical trial data with the scientific and medical communities, as well as the public through media coverage of the findings. Especially if published in a top-tier scientific journal, highlighting such presentation in a press release will provide visibility for the company as well as the extra level of validation of study findings.
SRRK move today could be what we see in AVXL
Buying for CTAD Nov 5th !
Buying and Holding for the Linda Leiu conference Nov 20th !
Imo. expected movers are LOACW, NWBO and AVXL
CTAD NOV 6th 11:02 am
What price could the stock be as we approach that presentation?
Data Lock means NO ONE knows, so until data is released i doubt anyone will release any hit pieces. And if good news, they cant. I trust Lappin did her homework especially after she caught Qwest.
Well said. First Late Breaking at CTAD, stock should be $8+ now.
You are welcome. She does her homework. Read the attached bio and how she uncovered accounting nightmares at Qwest before anyone else did. Nice to have her recommending NWBO.
http://www.gramercycapital.com/joan_lappin.html
http://www.gramercycapital.com/joan_lappin.html
She recommends NWBO. sane woman who found Qwest accounting problems.
Expect Gap opens daily and then huge move on news.
Shorts will be covering for weeks.
This article says $14-$28
https://seekingalpha.com/article/4378402-northwest-bio-wow
This article says $14-$28
https://seekingalpha.com/article/4378402-northwest-bio-wow
This article says $14-$28
https://seekingalpha.com/article/4378402-northwest-bio-wow
Someone posted this on Yahoo
The article below is from Joan Lappin...who Newsweek Business refers to as an investment guru
"Right now, NWBO is valued at less than $1 billion. If the trial is successful, and we will know quickly, this undervaluation will correct rapidly. Immunomedics was recently acquired for $21 billion by Gilead with a less promising drug. Like all biotech trials, this one can still fail. Do not spend more money than you can afford to lose but understand that this drug has the potential to alter all solid tumor cancer treatment for years to come."
Mentions a buyout of $25 billion that isnt as good as NWBO.